First human tests begin for experimental hypertension treatment
NCT ID NCT06823947
Summary
This early-stage study is testing the safety of a new drug called KK3910 for high blood pressure. Researchers will give single doses to healthy volunteers and multiple doses to people with hypertension to check for side effects. The study will also measure how the drug moves through the body to determine appropriate dosing for future research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS ESSENTIAL HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kitasato University Kitasato Institute Hospital
RECRUITINGMinato-ku, Tokyo, 108-8642, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Medical Corporation Heishinkai OPHAC Hospital
NOT_YET_RECRUITINGYodogawa, Osaka, 532-0003, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
SOUSEIKAI PS Clinic
NOT_YET_RECRUITINGHakata, Fukuoka, 812-0025, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.